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Background and Objectives. Atypical lipomas are uncommon, slow-growing benign tumors. While surgery has been the primary
treatment modality, we have managed some patients with radiation (RT) as a component of the treatment and have reported
their outcomes in this study.Methods. A retrospective review of all cases of extremity and trunk atypical lipomas in e Sarcoma
Database at the study institutionwas conducted.Results.irteen patients were identi�ed. All patients underwent surgical resection
at initial presentation and received pre- or postoperative radiation for subtotal resection (𝑛𝑛 𝑛 𝑛), local recurrence (𝑛𝑛 𝑛 𝑛), or
progressive disease (𝑛𝑛 𝑛 𝑛). e median total radiation dose was 50Gy. Median followup was 65.1 months. All patients treated
with RT remained free of disease at the last followup. No grade 3 or higher late toxicity from radiation was observed. No cases of
tumor dedifferentiation occurred. Conclusion. For recurrent or residual atypical lipomas, a combination of reexcision and RT can
provide long-term local control with acceptable morbidity. For recurrent tumors, pre-op RT of 50Gy appears to be an effective and
well-tolerated management approach.
1. Introduction
e term atypical lipoma was �rst introduced in 1974 [1] to
describe lobulated, well-circumscribed, large lesions that are
histologically characterized by mature adipocytes of varying
size and scattered atypical stromal cells with hyperchromatic
nuclei (Figure 1) [2, 3]. Atypical lipomas are slow-growing
tumors that typically affect the extremities and trunk. In the
absence of a dedifferentiated component, atypical lipomas do
not metastasize and pattern of failure is predominantly local
[3–11]. e primary treatment modality has been surgical
resection, with reexcision for recurrent lesions.
e role and utility of preoperative or adjuvant radiation
in management of these lesions is not well known. We have
managed some patients with recurrent or subtotally resected
tumors with radiation as a component of the treatment.
In this study, we review the outcomes of thirteen patients
with atypical lipoma treated with radiation therapy (RT)
at the Massachusetts General Hospital during the years of
1995–2010.
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F 1: Histologic presentation of atypical lipoma. Atypical
lipoma composed of mature fat and �brous tissue with scattered,
enlarged, hyperchromatic cells.
2. Methods
A retrospective review of all cases of atypical lipoma treated
with radiation at the Massachusetts General Hospital was
conducted. Patients were excluded if RT was completed
aer January 2010. irteen consecutively treated patients
were identi�ed, initially diagnosed between 1987 and 2007.
Median age at diagnosis was 54 (range: 36–76 years).
With the exception of one chest wall lesion, all lesions
were located in the upper (𝑛𝑛 𝑛 𝑛) or lower (𝑛𝑛 𝑛 𝑛) extremity.
Of the lower extremity lesions, seven were in the thigh and
one was in the calf. Of the upper extremity lesions, two were
in the forearm, one in the deltoid, and one in the proximal
arm.
Details of each patient and treatment are shown in
Table 1. Tumors were diagnosed based on reported histologic
features aer pathology review at Massachusetts General
Hospital. Toxicity was graded based on Common Terminol-
ogy Criteria for Adverse Events v4.0 (CTCAE).
Gross total resection (GTR) was de�ned as tumor
resected with negative margins. Subtotal resection (STR)
was de�ned as gross residual disease. Local recurrence was
de�ned as regrowth of tumor aer a gross total resection.
Progressive disease was de�ned as growth of residual tumor
aer STR.
All the patients underwent surgical resection at initial
presentation, either GTR (𝑛𝑛 𝑛 𝑛), STR (𝑛𝑛 𝑛 𝑛), or extent of
resection unknown (𝑛𝑛 𝑛 𝑛).
Of patients with GTR, local recurrence was identi�ed at
a mean of 58.5 months (range, 20.0–133.8 months) following
resection.e locally recurrent tumor was treated with either
preoperative RT (50Gy in 2Gy fractions) and GTR (𝑛𝑛 𝑛 𝑛),
or resection followed by postoperative RT (50–66Gy in 2Gy
fractions) (𝑛𝑛 𝑛 𝑛).
Of the group of four patients with STR, two were
monitored clinically and treated aer evidence of disease
progression, and the remaining two were treated adjuvantly
with radiation for the following reasons. e �rst adjuvantly
treated patient had atypical lipoma of the chest wall, and
underwent tumor excision at an outside institutionwith gross
residual disease. He presented with limb paresthesias prior
to resection. He was recommended radiation followed by
reexcision over observation due to his symptoms, and also
because it was felt that a local recurrence would be difficult
to resect given the tumor location. He received 50Gy in 2Gy
fractions, followed by gross total excision of residual tumor.
A second adjuvantly treated patient had subtotal excision
of tumor that was overlying the sciatic nerve. Adjuvant
radiation to 60Gy in 30 fractions was administered due to
concern of residual disease le within the region of the sciatic
nerve. e remaining two patients, who were monitored
clinically aer STR, ultimately required RT with (𝑛𝑛 𝑛 𝑛)
or without excision (𝑛𝑛 𝑛 𝑛) for progressive disease. e
�rst patient in this group had a subtotal excision of atypical
lipoma arising from the thigh, with postoperative scans
revealing slow growth of residual tumor. e patient opted
for reresection, 58.1 months aer initial resection. is was
followed by adjuvant radiation to 61.2Gy in 34 fractions.
e other patient underwent initial subtotal resection of an
anterior compartment tumor of the leg, and surgery was not
recommended due to potential functional morbidity (foot
drop). He ultimately received radiation to 70Gy in 2Gy
fractions to residual tumor, measuring 18.2 × 6.5 × 3.4 cm
in size. is was delivered with a combination of photons
and protons, 46.3 months aer initial resection, due to slow
increase in size. Posttreatment scans showed no further
tumor growth.
ree patients had surgery with extent of initial resection
unknown. One patient received excision, chemotherapy, and
reexcision (all delivered in Greece; details of surgical extent
and chemotherapy are unknown), followed by local recur-
rence aer 27.4 months, which was treated with preoperative
RT and excision.e second patient underwent two excisions
in a span of 12 years, followed by local recurrence 10.3
years aer last resection, also treated with preoperative RT
and excision. e third patient underwent three excisions
within a span of �ve years, followed by local recurrence 5
years aer last resection, and was managed with excision and
brachytherapy with RT delivered �ve days postoperatively
with low-dose rate Ir-192 brachytherapy to a dose of 60Gy
prescribed to 5mm from the plane of the implant.
3. Results
Median followup from time of last radiation treatment was
65.1months (range, 3.7–196.0months; average 73.1months).
Local tumor control was achieved in all 13 patients treated
with radiation. ere were no cases of metastatic disease or
tumor dedifferentiation on followup. Summary of treatment
is shown in Table 2.
One patient, who received preoperative RT (50Gy in
2Gy fractions), developed a postoperative wound infection,
requiring hospitalization and administration of IV antibiotics
two months aer surgery. She recovered fully.
No cases of grade 3 or higher late toxicity from radiation
were observed.ere were two patients who developed grade
1 lower extremity edema in the treated limb. is includes
the patient with grade 3 infection, as detailed above, and a
patient who received resection and postoperative RT aer
initial gross total resection. One patient developed grade 1
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T 2: Treatment and follow-up summary.
Sex Age at diagnosis(Y) Site Initial management Size of initial lesion
Time to LR/treatment of PD
(M) Treatment for progression/LR
F 47 igh GTR 6.0 × 6.0 × 6.0 20 Reop RT + GTR
F 76 igh GTR 4.0 × 3.0 × 1.5 20.2 Reop RT + GTR
M 65 Forearm GTR 15.0 × 5.0 × 5.0 36.7 Reop RT + GTR
F 73 igh GTR 6.0 × 9.0 124.2 GTR + postop RT
F 45 igh GTR 10.5 × 6.5 × 2 133.8 GTR + postop RT
RT indicates radiation; GTR: gross total resection, STR: subtotal resection, FU: follow-up, M: months.
T 3: Summary of outcomes reported for atypical lipomas in select series.
Author Year No. of patients Mean FU
(M)
LR Dedifferentiation
𝑛𝑛 (%) 𝑛𝑛 (%)
Evans et al. [12] 1979 22 9 (41%) 0
Azumi et al. [7] 1987 48 84 7 (15) 0
Weiss and Rao [8] 1992 46 108 20 (46) 3 (7)
Lucas et al. [9] 1994 32 112 15 (47) 6 (19)
Rozental et al. [13] 2002 31 84 16 (52) 2 (6)
Kooby et al. [3] 2004 91 47 20 (22) 3 (3)
Bassett et al. [14] 2005 51 52 14 (27) 1 (2)
Sommerville et al. [15] 2005 61 50 5 (8) 0
Evans [5] 2007 11a >120 1 (9) 0
Serpell and Chen [10] 2007 6b 18 3 (50) 1 (17)
Billing et al. [4] 2008 38 90 4 (10) 0
Mavrogenis et al. [6] 2011 67 81 5 (11) 1 (2)
FU indicates follow-up, M: months, LR: local recurrence.
aExtremity lipomas only, batypical lipomas only.
telangiectasias; this patient had received brachytherapy to
60Gy. Another patient, who was treated at initial presenta-
tion with subtotal excision followed by adjuvant RT (60Gy
in 2Gy fractions), developed grade 2 sciatic neuropathy,
requiring narcotics for pain control. Of note, she had tumor
overlying the sciatic nerve at presentation.
4. Discussion
Atypical lipomas are well-differentiated, slow-growing
tumors that typically occur in the trunk and extremities and
have a long natural history. Although surgery is the primary
treatment modality, the likelihood of local recurrence is
considered to be signi�cant. It is di�cult to estimate the
true rates of local failure from published series due to
the small number of patients and heterogeneity in tumor
classi�cation, but reported rates range from 8–52% (Table 3)
[1, 3, 5–10, 12, 14, 15]. Rates of tumor dedifferentiation
range from 0 to 13% in published reports [3–6, 8–10, 13–15].
No cases of tumor dedifferentiation occurred in this present
series.
Subclassi�cation of atypical lipomas has been explored
by several series in an effort to identify factors associated
with local recurrence; however, due to small sample sizes,
results have been inconclusive. One report by Kooby et al.
[3] reviewed 91 lipomatous tumors and identi�ed sclerosing
histology to be associated with higher likelihood of local
failure. A positive margin was also identi�ed to be associated
with increased failures, suggesting these subsets of patients
should receive reexcision and consideration of adjuvant
treatment.
Standard management of local recurrence is reexcision.
However, RT may have a role in providing long-term local
control, particularly in areas where wide margins are chal-
lenging to achieve. To our knowledge, to date, there has not
been any literature focusing on the use of RT in management
of recurrent or incompletely resected atypical lipoma.
In this paper, eleven patients were treated for recurrent
disease. All patients initially received surgical resection as
primary treatment, with average time to recurrence of 63.2
months. Of this group, ten received a combination of RT and
surgery and one received RT alone. At median followup of
48.7 months, all patients remained free of disease, demon-
strating that long-term control can be achieved with the
addition of RT.
Two patients received adjuvant RT at initial presentation
due to gross residual disease. At last followup (of 196.0 and
81.0 months, resp.), the patients remained free of recur-
rent disease, suggesting that long-term local control can be
achieved with RT even in the setting of residual tumor.
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e potential long-term morbidity of RT and surgery is
important to consider when devising a management strat-
egy. One patient, who received 60Gy of adjuvant radiation
following subtotal resection, developed late grade 2 sciatic
neuropathy. Preoperative RT is typically delivered to a lower
dose, typically 50Gy, and carries less risk of late �brosis
[16] with long-term control equivalent to postoperative
RT. Of patients with recurrent atypical lipomas, 6 received
preoperative RT followed by gross tumor resection, and 3
underwent surgery followed by adjuvant RT. No grade 3
or higher late toxicity from radiation was observed, and all
patients had control of their tumors.
In conclusion, atypical lipomas are slow-growing tumors
with a propensity to recur locally; thus, long-term followup
is recommended. RT can provide durable local control
for patient and is recommended for patients at especially
high risk of recurrence, due to multiply recurrent disease
or residual gross tumor. For recurrent tumors, our results
suggest a combination of reexcision and RT can provide long-
term local control with acceptable morbidity. In the setting
of gross residual disease, adjuvant RT can be considered to
prevent local progression.
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